LINDSAY HANNA: Open Payments
NPI 1699257907 · TEMPLETON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 40 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $179 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| Novo Nordisk Inc | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $60 |
| Exact Sciences Corporation | 3 | $54 |
| PFIZER INC. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $31 |
| Lilly USA, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: TRELEGY ELLIPTA, Kerendia, Ozempic, JARDIANCE, QULIPTA, The Cologuard Plus Collection Kit, PREVNAR 20, Veozah.
Industry payments across CA — which companies pay providers there.
